tiprankstipranks
Verona Pharma Plc (VRNA)
NASDAQ:VRNA

Verona Pharma (VRNA) Technical Analysis

572 Followers

Technical Sentiment

Overall Consensus
Buy
15Bullish
1Neutral
6Bearish
Technical Analysis Consensus
Sell
3Bullish
1Neutral
6Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Verona Pharma Plc’s (VRNA) Moving Averages Convergence Divergence (MACD) indicator is 1.41, suggesting Verona Pharma Plc is a Sell.
Verona Pharma Plc’s (VRNA) 20-Day exponential moving average is 16.51, while Verona Pharma Plc’s (VRNA) share price is $21.5, making it a Buy.
Verona Pharma Plc’s (VRNA) 50-Day exponential moving average is 15.40, while Verona Pharma Plc’s (VRNA) share price is $21.5, making it a Buy.

Verona Pharma (VRNA) Pivot Points

Jul 22, 2024, 11:53 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
15.50
16.73
18.97
20.21
22.45
23.68
25.92
Fibonacci
16.73
18.06
18.88
20.21
21.53
22.35
23.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verona Pharma (VRNA) Moving Averages

Jul 22, 2024, 11:53 PM
Period
Simple
Exponential
MA5
18.80Buy
19.17Buy
MA10
17.13Buy
17.83Buy
MA20
16.23Buy
16.51Buy
MA50
14.49Buy
15.40Buy
MA100
15.39Buy
15.48Buy
MA200
15.64Buy
15.96Buy
Verona Pharma Plc’s (VRNA) 10-Day exponential moving average is 17.83, while Verona Pharma Plc’s (VRNA) share price is $21.5, making it a Buy.
Verona Pharma Plc’s (VRNA) 100-Day exponential moving average is 15.48, while Verona Pharma Plc’s (VRNA) share price is $21.5, making it a Buy.
Verona Pharma Plc’s (VRNA) stock price is $21.5 and Verona Pharma Plc’s (VRNA) 50-day simple moving average is 14.49, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $21.5 and Verona Pharma Plc’s (VRNA) 100-day simple moving average is 15.39, creating a Buy signal.
Verona Pharma Plc’s (VRNA) stock price is $21.5 and Verona Pharma Plc’s (VRNA) 200-day simple moving average is 15.64, creating a Buy signal.

Verona Pharma (VRNA) Technical Indicators

Jul 22, 2024, 11:53 PM
Name
Value
Implied Action
RSI (14)
75.38
Sell
STOCH (9,6)
93.04
Sell
STOCHRSI (14)
93.04
Sell
MACD (12,26)
1.41
Sell
ADX (14)
45.11
Neutral
Williams %R
-14.36
Sell
CCI (14)
274.79
Sell
ATR (14)
1.25
-
Ultimate Oscillator
71.46
Buy
ROC
38.80
Buy
Verona Pharma Plc’s (VRNA) Relative Strength Index (RSI) is 75.38, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Trend Strength Indicator (ADX) is 45.11, creating a Neutral signal.
Verona Pharma Plc’s (VRNA) Commodity Channel Index (CCI) is 274.79, creating a Sell signal.
Verona Pharma Plc’s (VRNA) Price Rate of Change (ROC) is 38.80, creating a Buy signal.

FAQ

Is VRNA a Buy, Hold, or Sell?
Based on VRNA’s technical indicators, VRNA is a Buy.
    What is VRNA’s RSI (14)?
    VRNA’s RSI (14) is 75.38, which suggests VRNA is a Sell.
      What is VRNA’s MACD?
      VRNA’s MACD is 1.41, which suggests VRNA is a Sell.
        What is VRNA’s 5-day moving average?
        VRNA’s 5-day moving average is 18.80, which suggests VRNA is a Buy.
          What is VRNA’s 20-day moving average?
          VRNA 20-day moving average is 16.23, which suggests VRNA is a Buy.
            What is VRNA’s 50-day moving average?
            VRNA’s 50-day moving average is 14.49, which suggests VRNA is a Buy.
              What is VRNA’s 200-day moving average?
              VRNA’s 200-day moving average is 15.64, which suggests VRNA is a Buy.
                What is VRNA’s Williams % R (14)?
                VRNA’s Williams % R (14) is -14.36, which suggests VRNA is a Sell.
                  What is VRNA’s CCI (14)?
                  VRNA’s CCI (14) is 274.79, which suggests VRNA is a Sell.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis